Hepatitis B Serology in Patients with Rheumatic Diseases

BACKGROUND: Only limited data are available on the prevalence of hepatitis B in patients with proven rheumatic diseases and thus the risk of reactivation under immunosuppressive therapy. OBJECTIVE: To analyse hepatitis B serology in patients with rheumatic diseases prior to therapy. METHOD: In total...

Descripción completa

Detalles Bibliográficos
Autores principales: Feuchtenberger, Martin, Schäfer, Arne, Philipp Nigg, Axel, Rupert Kraus, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039958/
https://www.ncbi.nlm.nih.gov/pubmed/27708728
http://dx.doi.org/10.2174/1874312901610010039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039958/
https://www.ncbi.nlm.nih.gov/pubmed/27708728
http://dx.doi.org/10.2174/1874312901610010039

Ejemplares similares